VISUMAX FEMTOSECOND LASER

Femtosecond Laser System For Refractive Correction

FDA Premarket Approval P150040

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the visumax femtosecond laser. This device is indicated for use in small incision lenticule extraction (smile) for the reduction or elimination of myopia >= -1. 00 d to

DeviceVISUMAX FEMTOSECOND LASER
Classification NameFemtosecond Laser System For Refractive Correction
Generic NameFemtosecond Laser System For Refractive Correction
ApplicantCarl Zeiss Meditec, Inc.
Date Received2015-10-30
Decision Date2016-09-13
Notice Date2016-09-16
PMAP150040
SupplementS
Product CodeOTL
Docket Number16M-2735
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Carl Zeiss Meditec, Inc. 5160 Hacienda Drive dublin, CA 94568
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150040Original Filing
S011 2022-11-22 30-day Notice
S010 2022-05-23 30-day Notice
S009 2021-01-25 30-day Notice
S008 2020-11-19 Normal 180 Day Track
S007 2020-10-29 30-day Notice
S006 2020-09-08 30-day Notice
S005 2020-03-20 30-day Notice
S004 2018-12-11 Normal 180 Day Track No User Fee
S003 2018-03-23 Panel Track
S002 2018-02-28 Real-time Process
S001 2017-01-06 Real-time Process

NIH GUDID Devices

Device IDPMASupp
04049471100136 P150040 012
04049471100167 P150040 012
04049471100150 P150040 012
04049471100143 P150040 012
04049471095111 P150040 012

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.